Diseases, Conditions, Syndromes

Vaccine partnership raises hope for millions

Griffith University will partner with a Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc. for a new vaccine that could benefit millions.

Arthritis & Rheumatism

Biosimilar switching not suitable for all patients

The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2016) showed that when antibodies develop in response to the biological treatment Remicade (infliximab), they also cross-react ...

Arthritis & Rheumatism

Simultaneous diagnosis of SLE, pheochromocytoma described

(HealthDay)—A case of simultaneous diagnosis of systemic lupus erythematous (SLE) and pheochromocytoma, with disappearance of SLE after pheochromocytoma treatment, is described in a letter to the editor published online ...

Arthritis & Rheumatism

Tocilizumab treats rheumatoid arthritis after non-TNFi failure

(HealthDay)—For patients with rheumatoid arthritis (RA) and a first non-tumor necrosis factor inhibitor (TNFi) failure, treatment with tocilizumab seems more efficacious than abatacept or rituximab, according to a study ...

Arthritis & Rheumatism

Five genes tied to osteoarthritis progression

(HealthDay)—Five genes may serve as biomarkers for osteoarthritis (OA) progression, according to a study published online Feb. 2 in the International Journal of Rheumatic Diseases.

Arthritis & Rheumatism

Low vitamin D linked to dry eye syndromes

(HealthDay)—Vitamin D deficiency is associated with dry eye and impaired tear function, according to a study published in the January issue of the International Journal of Rheumatic Diseases.

page 18 from 34